Can you take Viagra after gastric sleeve surgery? It is a question many men face as they recover and adjust to life after a sleeve gastrectomy. Sildenafil (Viagra) is a widely used treatment for erectile dysfunction (ED), but the anatomical and physiological changes that follow bariatric surgery can influence how oral medications are absorbed and how effectively they work. This article explores what the current evidence says, which factors may affect sildenafil's performance post-surgery, key safety considerations, and when to seek medical advice — helping you have an informed conversation with your GP or bariatric team.

How Gastric Sleeve Surgery Affects Medication Absorption

Sleeve gastrectomy reduces stomach volume and accelerates gastric emptying, which may alter drug absorption rates, though the small intestine — the primary absorption site — remains intact and unaltered.

Gastric sleeve surgery (sleeve gastrectomy) removes approximately 75–80% of the stomach, creating a narrow, tube-shaped pouch. This anatomical change has significant implications not only for food intake but also for how medications are absorbed into the bloodstream. Understanding these changes is important before taking any prescription medicine post-operatively, including sildenafil (Viagra).

The stomach plays a central role in breaking down oral medications, particularly those that dissolve best in an acidic environment. After a sleeve gastrectomy, gastric acid production may be reduced because a proportion of the acid-secreting cells are removed. This can theoretically alter the dissolution of certain drugs, though the clinical significance varies considerably between medicines and individuals.

Unlike gastric bypass surgery, the sleeve does not reroute the small intestine, meaning the primary site of drug absorption — the duodenum and jejunum — remains intact. However, the reduced stomach volume means that medications may pass through the gastrointestinal tract more rapidly. This accelerated gastric emptying could theoretically affect:

• The time it takes for a drug to reach peak plasma concentration

• The overall bioavailability of some medications

• The duration of therapeutic effect for certain drugs

These effects are not universal and vary between drug classes and individual patients. Practically, the Specialist Pharmacy Service (SPS) and the British Obesity and Metabolic Surgery Society (BOMSS) advise that, in the early post-operative period, modified-release and enteric-coated formulations should generally be avoided where possible, as their absorption may be unpredictable. Immediate-release, dispersible, or liquid formulations are preferred where clinically appropriate. Medicines with a narrow therapeutic index warrant particular attention.

Patients who have undergone bariatric surgery are advised to have their full medication regimen reviewed by their GP or a bariatric pharmacist, particularly in the months following the procedure when physiological changes are most pronounced. This review should include any medicines taken on an as-needed basis, such as sildenafil. Clinical response should be monitored and doses adjusted accordingly.

Taking Viagra After Bariatric Surgery: What the Evidence Shows

There is no MHRA or NICE contraindication to sildenafil after sleeve gastrectomy, but direct pharmacokinetic evidence is limited and individual clinical assessment remains essential before use.

Sildenafil, marketed as Viagra, is a phosphodiesterase type 5 (PDE5) inhibitor licensed for the treatment of erectile dysfunction (ED) in adult men. It works by enhancing the effects of nitric oxide in the corpus cavernosum of the penis, relaxing smooth muscle and increasing blood flow to facilitate an erection in response to sexual stimulation. It is available on prescription in the UK and is also available as a Pharmacy (P) medicine — Viagra Connect 50 mg — supplied following assessment by a pharmacist.

There is currently limited direct clinical evidence specifically examining sildenafil pharmacokinetics following sleeve gastrectomy. Most available data on drug absorption after bariatric surgery focuses on gastric bypass procedures rather than sleeve gastrectomy. Pharmacokinetic studies on other orally administered drugs following sleeve gastrectomy suggest that absorption profiles can vary considerably between individuals, and findings cannot be straightforwardly extrapolated to sildenafil.

Because sildenafil is primarily absorbed in the small intestine — which remains anatomically unchanged after a sleeve procedure — absorption is generally expected to be maintained. However, the reduced stomach volume and faster gastric transit may influence the rate of absorption in some individuals; the extent of any such effect is uncertain and not consistently demonstrated. Patients should not assume that the drug will behave identically to how it did before surgery.

It is important to note that there is no specific contraindication from the MHRA or in NICE guidance prohibiting the use of sildenafil after sleeve gastrectomy. However, the absence of a specific contraindication does not replace the need for individual clinical assessment. Patients should always consult their GP or bariatric team before resuming or initiating sildenafil post-surgery.

Sildenafil is absolutely contraindicated with nitrate medicines (such as glyceryl trinitrate or isosorbide mononitrate) and with riociguat (a soluble guanylate cyclase stimulator used in pulmonary hypertension), as these combinations can cause a severe and potentially life-threatening fall in blood pressure. Patients taking either of these medicines must not use sildenafil.

Factors That May Alter Sildenafil's Effectiveness Post-Surgery

Faster gastric transit, smaller meal sizes, nutritional deficiencies, weight-related cardiovascular improvements, and concurrent CYP3A4-inhibiting medicines can all influence how effectively sildenafil works after sleeve surgery.

Several physiological and lifestyle factors associated with gastric sleeve surgery may influence how effectively sildenafil works in the post-operative period. Being aware of these factors can help patients and clinicians make more informed decisions about dosing and timing.

Key factors to consider include:

• Gastric transit: The sleeve stomach empties more quickly than a normal stomach. This may theoretically influence the rate at which sildenafil is absorbed in some individuals, though the clinical impact is uncertain and will vary between patients.

• Food and grapefruit juice: According to the sildenafil Summary of Product Characteristics (SmPC), sildenafil should be taken on an empty stomach or with a light meal for optimal effect, as high-fat meals can delay absorption and reduce peak plasma concentration. Grapefruit juice should be avoided, as it inhibits the CYP3A4 enzyme and can increase sildenafil plasma levels, potentially heightening the risk of side effects. Post-sleeve patients typically eat smaller, lower-fat meals, which may support more consistent absorption.

• Nutritional deficiencies: Bariatric surgery can lead to deficiencies in micronutrients such as zinc, which may contribute to changes in testosterone production and sexual function. Vitamin D deficiency is also common after bariatric surgery and may play a role in overall wellbeing, though its direct effect on erectile function is less clearly established. Addressing nutritional deficiencies through supplementation and monitoring — as recommended in bariatric follow-up protocols — may independently support sexual health.

• Weight loss and cardiovascular improvement: Significant weight loss following surgery often improves vascular health, insulin sensitivity, and testosterone levels — all of which can positively influence erectile function. Some men find that ED improves naturally after surgery without the need for pharmacological intervention.

• Concurrent medications: Many bariatric patients take proton pump inhibitors (PPIs) post-operatively. A direct clinically significant effect of PPIs on sildenafil absorption has not been established, and any interaction is considered uncertain; this should not be a primary concern but may be worth noting to the prescribing clinician.

• CYP3A4 inhibitors: Medicines that inhibit the CYP3A4 enzyme — including ritonavir and other HIV protease inhibitors, ketoconazole, itraconazole, and clarithromycin — can significantly increase sildenafil plasma concentrations. Dose limits or avoidance may be required; refer to the SmPC or BNF for specific guidance.

Individual variation is significant, and what works well for one patient may not be appropriate for another. A personalised approach, guided by a healthcare professional, remains the safest course of action.

Risks and Precautions to Discuss With Your Clinical Team

Sildenafil is absolutely contraindicated with nitrates and riociguat; cardiovascular fitness, concurrent medications, and psychological factors should all be assessed by a clinician before initiating treatment post-surgery.

Sildenafil carries a well-established safety profile when used appropriately, but there are specific precautions that are particularly relevant in the context of post-bariatric surgery care. Before taking sildenafil after a gastric sleeve procedure, patients should have an open discussion with their GP or bariatric team.

Important safety considerations include:

• Cardiovascular status: Sildenafil causes vasodilation and a modest reduction in blood pressure. Patients who have recently undergone major surgery or who have underlying cardiovascular conditions should be assessed for cardiac fitness before using PDE5 inhibitors. NICE CKS guidance on erectile dysfunction recommends that men with significant cardiovascular disease discuss the risks of sexual activity itself before initiating ED treatment, and that PDE5 inhibitors should not be used where sexual activity is clinically inadvisable.

• Contraindications: Sildenafil is absolutely contraindicated with nitrate medicines (e.g., glyceryl trinitrate, isosorbide mononitrate) and with riociguat, due to the risk of severe hypotension. It should also be used with caution alongside alpha-blockers, antihypertensives, and strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, clarithromycin), which can substantially increase sildenafil exposure. Refer to the BNF or sildenafil SmPC for a full list of interactions.

• Hereditary retinal disorders: Sildenafil should be used with caution in patients with hereditary degenerative retinal disorders such as retinitis pigmentosa, as per the SmPC.

• Dosing: According to the sildenafil SmPC and BNF, the standard starting dose is 50 mg taken as required, approximately one hour before sexual activity. A lower starting dose of 25 mg is recommended in older adults, those with hepatic impairment, significant renal impairment, or those taking strong CYP3A4 inhibitors or alpha-blockers. The dose may be increased to 100 mg or reduced to 25 mg based on response and tolerability. Any dose adjustment following bariatric surgery should be clinician-led and guided by individual response, rather than routinely lowering the starting dose solely on the basis of surgery.

• Psychological factors: Weight loss surgery can have a profound psychological impact. Body image changes, relationship dynamics, and post-operative anxiety may all contribute to ED. These factors should be explored alongside any pharmacological treatment.

Patients should never purchase sildenafil from unregulated online sources. In the UK, it is available safely via registered online pharmacies regulated by the General Pharmaceutical Council (GPhC), as a Pharmacy (P) medicine (Viagra Connect 50 mg) following pharmacist assessment, or on NHS prescription.

When to Seek Medical Advice About Erectile Dysfunction After Surgery

Consult your GP if ED persists for more than a few weeks post-operatively or causes distress; seek emergency care immediately for chest pain, sudden vision loss, or a prolonged erection lasting over four hours.

Erectile dysfunction following gastric sleeve surgery is not uncommon, particularly in the early post-operative period. The physical stress of surgery, hormonal fluctuations, nutritional changes, and psychological adjustment can all temporarily affect sexual function. In many cases, ED improves as the body adapts and weight loss progresses — but this is not always the case, and professional guidance should be sought when needed.

You should contact your GP if:

• ED persists for more than a few weeks post-operatively and is causing distress

• You experience a sudden change in sexual function that was not present before surgery

• You have symptoms that may suggest a hormonal imbalance, such as fatigue, reduced libido, or mood changes

• You are unsure whether sildenafil is safe to take alongside your current post-operative medication regimen

• You experience any side effects after taking sildenafil, including headache, flushing, visual disturbances, or indigestion

Seek emergency medical attention — call 999 or go to your nearest A&E — if you experience:

• Chest pain or tightness during or after sexual activity

• Sudden loss of vision in one or both eyes

• A prolonged erection lasting more than four hours (priapism), which requires immediate treatment to prevent permanent injury

If you think you have experienced a side effect from sildenafil, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk. Reporting helps the MHRA monitor the safety of medicines in the UK.

Experiencing these side effects? Our pharmacists can help you navigate them →

Your GP may refer you to a urology or sexual health clinic, or back to your bariatric team, depending on the suspected cause. Blood tests to assess testosterone, thyroid function, and nutritional markers are often a useful starting point. The NHS also provides access to psychosexual counselling services, which can be highly effective when psychological factors are contributing to ED.

In summary, while there is no specific prohibition on taking sildenafil after a gastric sleeve procedure, the altered physiology warrants careful clinical consideration. Open communication with your healthcare team is the most important step towards safe and effective management of erectile dysfunction in this context.

Frequently Asked Questions